World's Best Scientists 2026 revealed!
Giovanni Targher

Giovanni Targher

D-Index & Metrics

Medicine

D-Index
125
Citations
72541
World Ranking
3041
National Ranking
78

Overview

Giovanni Targher is affiliated with the University of Verona in Italy and has an extensive publication record in the field of medicine, with a particular focus on liver disease and metabolic disorders. Their research spans several subfields, including epidemiology, endocrinology, diabetes and metabolism, hepatology, surgery, and cardiology and cardiovascular medicine.

Their work frequently appears in prominent scientific journals, with notable publication venues including:

  • Nutrition Metabolism and Cardiovascular Diseases
  • Liver International
  • Gut
  • Diabetes Obesity and Metabolism
  • Journal of Hepatology

Giovanni Targher's main topics of scientific investigation cover:

  • Liver Disease Diagnosis and Treatment
  • Diet, Metabolism, and Disease
  • Liver Disease and Transplantation
  • Pancreatitis Pathology and Treatment
  • Diabetes Treatment and Management
  • Liver Diseases and Immunity
  • Alcohol Consumption and Health Effects

Their recent papers include:

  • A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement (2020), published in Journal of Hepatology
  • The complex link between NAFLD and type 2 diabetes mellitus - mechanisms and treatments (2021), published in Nature Reviews Gastroenterology & Hepatology
  • NAFLD and increased risk of cardiovascular disease: clinical associations, pathophysiological mechanisms and pharmacological implications (2020), published in Gut

Giovanni Targher has collaborated extensively with several co-authors frequently appearing alongside them in publications, including:

  • Christopher D. Byrne
  • Ming-Hua Zheng
  • Alessandro Mantovani
  • Kenneth I. Zheng
  • Luca Valenti

The scope of Giovanni Targher's research indicates a multidisciplinary approach, integrating hepatology with endocrinology and cardiovascular medicine to address complex interrelations between metabolic dysfunctions, liver diseases, and cardiovascular outcomes.

Best Publications

  • Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity.

    E Bonora;G Targher;M Alberiche;R C Bonadonna

  • A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement.

    Mohammed Eslam;Philip N. Newsome;Shiv K. Sarin;Quentin M. Anstee

  • NAFLD: A multisystem disease

    Christopher D. Byrne;Christopher D. Byrne;Giovanni Targher

  • Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease

    Giovanni Targher;Christopher P. Day;Enzo Bonora

  • Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis.

    Quentin M. Anstee;Giovanni Targher;Christopher P. Day

  • Prevalence of insulin resistance in metabolic disorders: the Bruneck Study.

    Enzo Bonora;S Kiechl;J Willeit;F Oberhollenzer

  • Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis

    Giovanni Targher;Christopher D. Byrne;Amedeo Lonardo;Giacomo Zoppini

  • Relation between red blood cell distribution width and inflammatory biomarkers in a large cohort of unselected outpatients.

    Giuseppe Lippi;Giovanni Targher;Martina Montagnana;Gian Luca Salvagno

  • Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases.

    Leon A Adams;Quentin M Anstee;Herbert Tilg;Giovanni Targher

  • Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta-analysis.

    Stefano Ballestri;Stefano Zona;Giovanni Targher;Dante Romagnoli

  • HOMA-estimated insulin resistance is an independent predictor of cardiovascular disease in type 2 diabetic subjects: prospective data from the Verona Diabetes Complications Study.

    Enzo Bonora;Gianni Formentini;Francesco Calcaterra;Simonetta Lombardi

  • 25-Hydroxyvitamin D deficiency is independently associated with cardiovascular disease in the Third National Health and Nutrition Examination Survey

    Jessica Kendrick;Giovanni Targher;Gerard Smits;Michel Chonchol

  • Hypertension, diabetes, atherosclerosis and NASH: Cause or consequence?

    Amedeo Lonardo;Fabio Nascimbeni;Alessandro Mantovani;Giovanni Targher

  • NAFLD and increased risk of cardiovascular disease: clinical associations, pathophysiological mechanisms and pharmacological implications

    Giovanni Targher;Christopher D Byrne;Herbert Tilg

  • Increased risk of cardiovascular disease in non-alcoholic fatty liver disease: causal effect or epiphenomenon?

    Giovanni Targher;F. Marra;G. Marchesini

  • The complex link between NAFLD and type 2 diabetes mellitus — mechanisms and treatments

    Giovanni Targher;Kathleen E Corey;Christopher D Byrne;Christopher D Byrne;Michael Roden

  • Nonalcoholic Fatty Liver Disease and Risk of Incident Type 2 Diabetes: A Meta-analysis

    Alessandro Mantovani;Christopher D Byrne;Christopher D Byrne;Enzo Bonora;Giovanni Targher

  • Obesity Is a Risk Factor for Greater COVID-19 Severity.

    Feng Gao;Kenneth I. Zheng;Xiao Bo Wang;Qing Feng Sun

  • Epidemiological modifiers of non-alcoholic fatty liver disease: Focus on high-risk groups

    Amedeo Lonardo;Stefano Bellentani;Curtis K. Argo;Stefano Ballestri

  • High Serum Uric Acid as a Novel Risk Factor for Type 2 Diabetes Response to Dehghan et al.

    Giuseppe Lippi;Giovanni Targher;Martina Montagnana;Gian Luca Salvagno

Frequent Co-Authors

Giuseppe Lippi
Giuseppe Lippi University of Verona
Christopher D. Byrne
Christopher D. Byrne University of Southampton
Enzo Bonora
Enzo Bonora University of Verona
Massimo Franchini
Massimo Franchini University of Verona
Michele Muggeo
Michele Muggeo University of Verona
Michel Chonchol
Michel Chonchol University of Colorado Anschutz Medical Campus
Luca Valenti
Luca Valenti University of Milan
Valerio Nobili
Valerio Nobili Sapienza University of Rome
Herbert Tilg
Herbert Tilg Innsbruck Medical University
Emmanuel J. Favaloro
Emmanuel J. Favaloro Westmead Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring medical studies in the USA offers many alternative online degree options that can boost your career in healthcare. For those passionate about preventive health and wellness, the best online nutrition degree programs open doors in nutrition counseling, research, and public health.

If you’re interested in healthcare leadership, accredited online mha programs provide a pathway to management roles in hospitals and health organizations. Nurses aiming to advance their education without time-consuming practical components can enroll in rn to bsn no clinical hours online programs, which focus on theoretical knowledge and professional development.

For experienced nurses wanting a doctorate, there are various accelerated dnp programs that enable faster completion and entry into advanced practice, education, or leadership roles. With these diverse online options, you can tailor a healthcare career path that fits your interests and lifestyle.

Best Scientists Citing Giovanni Targher

Trending Scientists

Recently Published Articles